BACKGROUND: Although rare, transfusion-associated GVHD (TA-GVHD) is a fatal complication of blood transfusion in which active lymphocytes from the donor attack and destroy recipient organs and tissues. STUDY DESIGN AND METHODS: A search of patient records was carried out at the American University of Beirut-Medical Center, looking for patients who developed TA-GVHD over a 10-year period extending from 1991 to 2001. Relevant information was collected and analyzed. RESULTS: A total of 10 records were found as a result of this search. All were immunocompetent and received fresh nonleukoreduced, nonirradiated blood. The majority received the transfusion at outside periphery hospitals. They received different treatment modalities. The mortality rate was 100 percent. CONCLUSION: TA-GVHD is a serious complication with very high mortality. Effective prevention guidelines should be established in Lebanon including irradiation and the creation of a central blood bank.
BACKGROUND: Although rare, transfusion-associated GVHD (TA-GVHD) is a fatal complication of blood transfusion in which active lymphocytes from the donor attack and destroy recipient organs and tissues. STUDY DESIGN AND METHODS: A search of patient records was carried out at the American University of Beirut-Medical Center, looking for patients who developed TA-GVHD over a 10-year period extending from 1991 to 2001. Relevant information was collected and analyzed. RESULTS: A total of 10 records were found as a result of this search. All were immunocompetent and received fresh nonleukoreduced, nonirradiated blood. The majority received the transfusion at outside periphery hospitals. They received different treatment modalities. The mortality rate was 100 percent. CONCLUSION: TA-GVHD is a serious complication with very high mortality. Effective prevention guidelines should be established in Lebanon including irradiation and the creation of a central blood bank.
Authors: Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Chris Yuk Kwan Tang; Vijay H D Kamath; Prudence Wing Hang Cheung; Jason Pui Yin Cheung Journal: BMC Musculoskelet Disord Date: 2021-02-26 Impact factor: 2.362
Authors: Gerda C Leitner; Gerhard Hagn; Laura Niederstaetter; Andrea Bileck; Kerstin Plessl-Walder; Michaela Horvath; Vera Kolovratova; Andreas Tanzmann; Alexander Tolios; Werner Rabitsch; Philipp Wohlfarth; Christopher Gerner Journal: Biomolecules Date: 2022-09-07
Authors: Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida Journal: PLoS One Date: 2013-06-07 Impact factor: 3.240